It is a trading private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 | Mumbai, Maharashtra, India | ActiveAsclepius Allied Pharma Private Limited, a active private limited company, was established on 15 September 2005 in Mumbai, Maharashtra, India. Engaging in retail trading within the trading sector, it holds CIN: U24230MH2005PTC156279. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Shailesh Popatlal Parekh (Director), Narendra Kapoor Singh (Director). Past directors included Vrushali Nitin Thakur, Swati Sudheer Thosar, Prakash Manohar Rao. Its latest AGM occurred on 28 September 2018, with the balance sheet filed on 31 March 2018. It is based at Shop No. 12, Akash Apartment, Mamlatdar Wadi Cross Road No. 4, Malad (, West), Mumbai, Maharashtra, 400064.
U24230MH2005PTC156279
156279
15 September 2005
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Asclepius Allied Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Popatlal Parekh | Director | 11 Apr 2011 | Current |
| Narendra Kapoor Singh | Director | 11 Apr 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Apr 2011 | Past |
| Pramod Abcsdd | Director | 09 May 2006 | Past |
| Pramod Abcsdd | Director | 20 Apr 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Asclepius Allied Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Asclepius Allied Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Asclepius Allied Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Asclepius Allied Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asclepius Allied Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Asclepius Allied Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2018 as per latest MCA records. was documented.
Progress on Asclepius Allied Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was documented.
The activity Shailesh Popatlal Parekh was appointed as a Director was appointed as a Director on 11 Apr 2011 & has been associated with this company since 14 years 7 months . was completed.
The activity Narendra Kapoor Singh was appointed as a Director was appointed as a Director on 11 Apr 2011 & has been associated with this company since 14 years 7 months . was completed.
Progress on Asclepius Allied Pharma Private Limited was registered on 15 Sep 2005 with Roc Mumbai & aged 20 years 2 months as per MCA records. was documented.
The CIN of Asclepius Allied Pharma Private Limited is U24230MH2005PTC156279.
Asclepius Allied Pharma Private Limited is headquartered at Shop No. 12, Akash Apartment, Mamlatdar Wadi Cross Road No. 4, Malad (, West), Mumbai, Maharashtra, 400064.
Asclepius Allied Pharma Private Limited was incorporated on 15 September 2005.
The current directors of Asclepius Allied Pharma Private Limited are
The primary industry of Asclepius Allied Pharma Private Limited is Trading.
Asclepius Allied Pharma Private Limited is unlisted.
The authorized capital of Asclepius Allied Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Asclepius Allied Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX